首页 > 最新文献

Gastroenterology and Hepatology From Bed to Bench最新文献

英文 中文
Resting functional magnetic resonance images of the brain in functional gastrointestinal diseases: a concise review of the literature. 功能性胃肠疾病的静息脑功能磁共振图像:文献综述。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i2.2987
Parsia Noori Mirtaheri, Saba Mehrtabar, Reza Shah Hosseini, Kianoush Shahryari, SeyedAbbas Pakmehr, Arash Rahimi, Sourena Mohammad Hashem, Seyed Amirabbas Shahidi Marnani, Shaghayegh Karami, Mahsa Sadeghi, Yeganeh Azhdary Moghaddam, Aida Azhdari Moghaddam, Niloofar Deravi, Mahsa Asadi Anar

Functional gastrointestinal disorders (FGID) are prevalent illnesses associated with diminished quality of life and increased healthcare utilization. These conditions influence gut sensitivity, motility, microbiota, immunological function, and nervous processing in the brain. Chronic symptoms, including pain and dyspepsia, are exacerbated by maladaptive patient behaviors, stress, and co-morbidity. Studies of functional neuroimaging reveal increased brain responses in regions associated with gut sensory processing and salient cues, altered central regulation of endocrine and autonomic nerve responses, and aberrant connections in pain processing and the default mode network. This neuroimaging helps us understand the pathophysiology and outcomes of patients better. From the standpoint of brain connection, research in this area can further our understanding of the central pathophysiology of FGID and pave the way for the objective diagnosis and development of novel therapeutics for FGID. Prospective Neuroimaging research may change from brain mapping to clinical prognosis prediction due to technological advances in machine learning algorithms used in imaging. The usefulness and revelations of functional brain imaging are highlighted in this review, along with the areas that require development and, lastly, recommendations for future research.

功能性胃肠疾病(FGID)是与生活质量下降和医疗保健使用率增加相关的普遍疾病。这些情况影响肠道敏感性、运动性、微生物群、免疫功能和大脑的神经处理。慢性症状,包括疼痛和消化不良,会因患者行为不适应、压力和合并症而加重。功能性神经影像学研究显示,与肠道感觉处理和显著线索相关的区域的大脑反应增加,内分泌和自主神经反应的中枢调节改变,疼痛处理和默认模式网络的异常连接。这种神经成像有助于我们更好地了解患者的病理生理学和预后。从脑连接的角度来看,这一领域的研究可以进一步加深我们对FGID中心病理生理的认识,为FGID的客观诊断和新疗法的开发铺平道路。由于成像中使用的机器学习算法的技术进步,前瞻性神经影像学研究可能从脑制图转变为临床预后预测。本文重点介绍了功能性脑成像的有用性和启示,以及需要发展的领域,最后对未来的研究提出了建议。
{"title":"Resting functional magnetic resonance images of the brain in functional gastrointestinal diseases: a concise review of the literature.","authors":"Parsia Noori Mirtaheri, Saba Mehrtabar, Reza Shah Hosseini, Kianoush Shahryari, SeyedAbbas Pakmehr, Arash Rahimi, Sourena Mohammad Hashem, Seyed Amirabbas Shahidi Marnani, Shaghayegh Karami, Mahsa Sadeghi, Yeganeh Azhdary Moghaddam, Aida Azhdari Moghaddam, Niloofar Deravi, Mahsa Asadi Anar","doi":"10.22037/ghfbb.v18i2.2987","DOIUrl":"10.22037/ghfbb.v18i2.2987","url":null,"abstract":"<p><p>Functional gastrointestinal disorders (FGID) are prevalent illnesses associated with diminished quality of life and increased healthcare utilization. These conditions influence gut sensitivity, motility, microbiota, immunological function, and nervous processing in the brain. Chronic symptoms, including pain and dyspepsia, are exacerbated by maladaptive patient behaviors, stress, and co-morbidity. Studies of functional neuroimaging reveal increased brain responses in regions associated with gut sensory processing and salient cues, altered central regulation of endocrine and autonomic nerve responses, and aberrant connections in pain processing and the default mode network. This neuroimaging helps us understand the pathophysiology and outcomes of patients better. From the standpoint of brain connection, research in this area can further our understanding of the central pathophysiology of FGID and pave the way for the objective diagnosis and development of novel therapeutics for FGID. Prospective Neuroimaging research may change from brain mapping to clinical prognosis prediction due to technological advances in machine learning algorithms used in imaging. The usefulness and revelations of functional brain imaging are highlighted in this review, along with the areas that require development and, lastly, recommendations for future research.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 2","pages":"164-176"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145039989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of primary sclerosing cholangitis (PSC) in Iranian adult patients with inflammatory bowel disease (IBD) or liver disorders: systematic review and meta-analysis. 伊朗成年炎症性肠病(IBD)或肝脏疾病患者中原发性硬化性胆管炎(PSC)的患病率:系统回顾和荟萃分析
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i1.3046
Ehsaneh Taheri, Behzad Hatami, Fatemeh Baghalha, Sara Ashtari, Zahra Nosrati, Mohammad Reza Zali

Aim: To evaluate the prevalence of primary sclerosing cholangitis (PSC) among Iranian adult patients with inflammatory bowel disease (IBD) or liver disorders.

Background: PSC is a rare and chronic liver disease characterized by inflammation, fibrosis, and intra- and/or extrahepatic bile duct structure.

Methods: A systematic review and meta-analysis was conducted. The Web of Science, Scopus, Pubmed, Embase, Google Scholar, and local databases, including the IranDoc, IranMedex, SID, and MagIran databases, were searched for studies published before 6th February 2023 for the prevalence of PSC among Iranian adults.

Results: In total, 22 articles involving 19,747 Iranian participants were included in this meta-analysis. The overall pooled prevalence of PSC was 8% (95% CI: 5%-12%). Additionally, the prevalence of PSC stratified by gender was calculated based on four studies (n = 1402). The pooled prevalence of PSC was estimated to be 20% (95% CI: 11-31%) in males and 12% (95% CI: 3-38%) in females. The pooled prevalence of PSC was 6% (95% CI: 4-9%) in patients with IBD and 14% (95% CI: 8-23%) in patients with liver transplantation (LT).

Conclusion: The pooled prevalence of PSC was 8% in Iranian adults, and the prevalence was greater in males than in females.

目的:评估伊朗成年炎症性肠病(IBD)或肝脏疾病患者中原发性硬化性胆管炎(PSC)的患病率。背景:PSC是一种罕见的慢性肝病,以炎症、纤维化和肝内和/或肝外胆管结构为特征。方法:进行系统综述和荟萃分析。我们检索了Web of Science、Scopus、Pubmed、Embase、b谷歌Scholar和本地数据库,包括IranDoc、IranMedex、SID和MagIran数据库,检索了2023年2月6日之前发表的关于伊朗成年人PSC患病率的研究。结果:本荟萃分析共纳入22篇文章,涉及19,747名伊朗参与者。PSC的总总患病率为8% (95% CI: 5%-12%)。此外,根据4项研究(n = 1402)计算按性别分层的PSC患病率。男性PSC的总患病率估计为20% (95% CI: 11-31%),女性为12% (95% CI: 3-38%)。IBD患者PSC的总患病率为6% (95% CI: 4-9%),肝移植(LT)患者PSC的总患病率为14% (95% CI: 8-23%)。结论:伊朗成人PSC总患病率为8%,男性患病率高于女性。
{"title":"Prevalence of primary sclerosing cholangitis (PSC) in Iranian adult patients with inflammatory bowel disease (IBD) or liver disorders: systematic review and meta-analysis.","authors":"Ehsaneh Taheri, Behzad Hatami, Fatemeh Baghalha, Sara Ashtari, Zahra Nosrati, Mohammad Reza Zali","doi":"10.22037/ghfbb.v18i1.3046","DOIUrl":"10.22037/ghfbb.v18i1.3046","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the prevalence of primary sclerosing cholangitis (PSC) among Iranian adult patients with inflammatory bowel disease (IBD) or liver disorders.</p><p><strong>Background: </strong>PSC is a rare and chronic liver disease characterized by inflammation, fibrosis, and intra- and/or extrahepatic bile duct structure.</p><p><strong>Methods: </strong>A systematic review and meta-analysis was conducted. The Web of Science, Scopus, Pubmed, Embase, Google Scholar, and local databases, including the IranDoc, IranMedex, SID, and MagIran databases, were searched for studies published before 6th February 2023 for the prevalence of PSC among Iranian adults.</p><p><strong>Results: </strong>In total, 22 articles involving 19,747 Iranian participants were included in this meta-analysis. The overall pooled prevalence of PSC was 8% (95% CI: 5%-12%). Additionally, the prevalence of PSC stratified by gender was calculated based on four studies (n = 1402). The pooled prevalence of PSC was estimated to be 20% (95% CI: 11-31%) in males and 12% (95% CI: 3-38%) in females. The pooled prevalence of PSC was 6% (95% CI: 4-9%) in patients with IBD and 14% (95% CI: 8-23%) in patients with liver transplantation (LT).</p><p><strong>Conclusion: </strong>The pooled prevalence of PSC was 8% in Iranian adults, and the prevalence was greater in males than in females.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 1","pages":"10-20"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144741958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A gluten-free diet has a different effect on the iron profile of celiac disease and non-celiac gluten-sensitive patients with idiopathic iron deficiency anaemia. 无麸质饮食对乳糜泻和非乳糜泻麸质敏感的特发性缺铁性贫血患者的铁谱有不同的影响。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i2.3139
Mehrdad Haghazali, Mohammad Rostami-Nejad, Abbas Hajfathali, Luca Elli, Mohsen Norouzinia, Hamid Asadzadeh-Aghdaei, Amir Sadeghi, Mahshid Akhavan Rahnama, Azadeh Anbarlou, Haniye Ghasiyari, Hamid Mohaghegh-Shalmani, Mostafa Rezaei-Tavirani, Masiha Amiri, Mohammad Reza Zali

Aim: This study aimed to assess the impact of a six-week gluten-free diet (GFD) on the iron profiles of patients with non-celiac gluten sensitivity (NCGS) and CD.

Background: Iron-deficiency anaemia (IDA) is a significant clinical feature of gluten-related disorders, especially Celiac disease (CD).

Methods: The study included 29 CD patients (mean age 40.28 ± 15.57 years) and 29 NCGS patients (mean age 30.31 ± 7.78 years) presenting with IDA who were enrolled in the study during 2023-2024. Haemoglobin, serum iron, serum ferritin, total iron-binding capacity (TIBC), and transferrin saturation (TSAT) levels were assessed at the beginning and after six weeks of GFD. HLA typing was conducted using the Real-time PCR-based SYBR Green method.

Results: Ferritin levels significantly increased in both CD and NCGS groups after the GFD, from 43.7807 to 50.5279 ng/mL and 23.0862 to 42.9910 ng/mL, respectively. Moreover, serum iron and TSAT levels significantly increased in the NCGS group, from 64.8034 to 81.3466 μg/dL and 19.29 ± 11.70 to 23.99 ± 9.05, respectively (p = 0.003).

Conclusion: The most frequent symptoms in CD and NCGS patients were bloating/bone disease (62.1%) and bone disease (37.9%), respectively. GFD was effective in improving IDA in both CD and NCGS patients. Further research is necessary to assess the therapeutic effect of GFD in patients with gastrointestinal symptoms and IDA.

目的:本研究旨在评估6周无麸质饮食(GFD)对非乳糜泻麸质敏感性(NCGS)和CD患者铁谱的影响。背景:缺铁性贫血(IDA)是麸质相关疾病,尤其是乳糜泻(CD)的一个重要临床特征。方法:研究纳入2023-2024年期间29例CD患者(平均年龄40.28±15.57岁)和29例NCGS患者(平均年龄30.31±7.78岁)的IDA患者。血红蛋白、血清铁、血清铁蛋白、总铁结合能力(TIBC)和转铁蛋白饱和度(TSAT)水平在GFD开始和6周后进行评估。采用基于实时pcr的SYBR Green方法进行HLA分型。结果:GFD后,CD组和NCGS组的铁蛋白水平均显著升高,分别从43.7807至50.5279 ng/mL和23.0862至42.9910 ng/mL。NCGS组血清铁和TSAT水平分别从64.8034至81.3466 μg/dL和19.29±11.70至23.99±9.05显著升高(p = 0.003)。结论:CD和NCGS患者最常见的症状分别是腹胀/骨病(62.1%)和骨病(37.9%)。GFD对改善CD和NCGS患者的IDA均有效。需要进一步的研究来评估GFD对胃肠道症状和IDA患者的治疗效果。
{"title":"A gluten-free diet has a different effect on the iron profile of celiac disease and non-celiac gluten-sensitive patients with idiopathic iron deficiency anaemia.","authors":"Mehrdad Haghazali, Mohammad Rostami-Nejad, Abbas Hajfathali, Luca Elli, Mohsen Norouzinia, Hamid Asadzadeh-Aghdaei, Amir Sadeghi, Mahshid Akhavan Rahnama, Azadeh Anbarlou, Haniye Ghasiyari, Hamid Mohaghegh-Shalmani, Mostafa Rezaei-Tavirani, Masiha Amiri, Mohammad Reza Zali","doi":"10.22037/ghfbb.v18i2.3139","DOIUrl":"10.22037/ghfbb.v18i2.3139","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to assess the impact of a six-week gluten-free diet (GFD) on the iron profiles of patients with non-celiac gluten sensitivity (NCGS) and CD.</p><p><strong>Background: </strong>Iron-deficiency anaemia (IDA) is a significant clinical feature of gluten-related disorders, especially Celiac disease (CD).</p><p><strong>Methods: </strong>The study included 29 CD patients (mean age 40.28 ± 15.57 years) and 29 NCGS patients (mean age 30.31 ± 7.78 years) presenting with IDA who were enrolled in the study during 2023-2024. Haemoglobin, serum iron, serum ferritin, total iron-binding capacity (TIBC), and transferrin saturation (TSAT) levels were assessed at the beginning and after six weeks of GFD. HLA typing was conducted using the Real-time PCR-based SYBR Green method.</p><p><strong>Results: </strong>Ferritin levels significantly increased in both CD and NCGS groups after the GFD, from 43.7807 to 50.5279 ng/mL and 23.0862 to 42.9910 ng/mL, respectively. Moreover, serum iron and TSAT levels significantly increased in the NCGS group, from 64.8034 to 81.3466 μg/dL and 19.29 ± 11.70 to 23.99 ± 9.05, respectively (p = 0.003).</p><p><strong>Conclusion: </strong>The most frequent symptoms in CD and NCGS patients were bloating/bone disease (62.1%) and bone disease (37.9%), respectively. GFD was effective in improving IDA in both CD and NCGS patients. Further research is necessary to assess the therapeutic effect of GFD in patients with gastrointestinal symptoms and IDA.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 2","pages":"211-215"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145039824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolving etiologies of liver transplantation: a trend analysis from 2020 to 2024 at the main center of Iran. 不断发展的肝移植病因学:2020年至2024年伊朗主要中心的趋势分析
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i1.3035
Mohamad Jamalinia, Kamran Bagheri Lankarani, Seyed Ali Malek-Hosseini

Aim: This study aimed to analyze trends in the etiologies of liver transplants at Abu Ali Sina Hospital, Shiraz, Iran, from 2020 to 2024.

Background: Liver transplantation (LT) is a crucial treatment for end-stage liver disease (ESLD). Over time, the etiologies leading to LT have evolved due to changes in disease prevalence, advancements in medical treatments, and public health interventions.

Methods: Etiologies of LT were categorized into nine groups: acute liver failure, autoimmune disorders, alcoholic steatohepatitis, liver cancer, vascular, metabolic dysfunction-associated steatohepatitis (MASH), viral hepatitis, metabolic disorders, and others. Trend analysis was performed using Python 3.12 programming language with appropriate libraries.

Results: A total of 1579 patients, 59.9% male with a mean age of 45.12 years (SD: 13.52), were analyzed. Autoimmune disorders emerged as the leading cause of LT, increasing from 32.2% in 2020 to 40.6% in 2024 (p-trend = 0.039). Viral hepatitis cases decreased significantly from 18.1% to 3.0% (p-trend = 0.033). Liver cancer became the third leading cause in 2021, replacing viral hepatitis, while MASH consistently remained the second leading cause.

Conclusion: The significant shifts in LT etiologies underscore the success of public health interventions in reducing the burden of viral-related ESLD. Additionally, the findings highlight the need for ongoing research into the prevention, early diagnosis, and management of autoimmune liver diseases, MASH, and liver cancer. These findings provide critical insights for clinicians and policymakers to enhance liver disease management and allocate resources effectively.

目的:本研究旨在分析2020年至2024年伊朗设拉子Abu Ali Sina医院肝移植病因的趋势。背景:肝移植(LT)是治疗终末期肝病(ESLD)的重要手段。随着时间的推移,由于疾病患病率的变化、医学治疗的进步和公共卫生干预措施,导致肝移植的病因也发生了变化。方法:将肝移植的病因分为九组:急性肝功能衰竭、自身免疫性疾病、酒精性脂肪性肝炎、肝癌、血管、代谢功能障碍相关脂肪性肝炎(MASH)、病毒性肝炎、代谢紊乱和其他。采用Python 3.12编程语言,配合相应库进行趋势分析。结果:共分析1579例患者,其中男性占59.9%,平均年龄45.12岁(SD: 13.52)。自身免疫性疾病成为LT的主要原因,从2020年的32.2%上升到2024年的40.6% (p-trend = 0.039)。病毒性肝炎病例由18.1%下降至3.0% (p-trend = 0.033)。2021年,肝癌取代病毒性肝炎成为第三大死因,而MASH仍然是第二大死因。结论:肝移植病因的显著变化强调了公共卫生干预在减轻病毒相关ESLD负担方面的成功。此外,研究结果强调了对自身免疫性肝病、MASH和肝癌的预防、早期诊断和管理进行持续研究的必要性。这些发现为临床医生和政策制定者加强肝病管理和有效分配资源提供了重要见解。
{"title":"Evolving etiologies of liver transplantation: a trend analysis from 2020 to 2024 at the main center of Iran.","authors":"Mohamad Jamalinia, Kamran Bagheri Lankarani, Seyed Ali Malek-Hosseini","doi":"10.22037/ghfbb.v18i1.3035","DOIUrl":"10.22037/ghfbb.v18i1.3035","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to analyze trends in the etiologies of liver transplants at Abu Ali Sina Hospital, Shiraz, Iran, from 2020 to 2024.</p><p><strong>Background: </strong>Liver transplantation (LT) is a crucial treatment for end-stage liver disease (ESLD). Over time, the etiologies leading to LT have evolved due to changes in disease prevalence, advancements in medical treatments, and public health interventions.</p><p><strong>Methods: </strong>Etiologies of LT were categorized into nine groups: acute liver failure, autoimmune disorders, alcoholic steatohepatitis, liver cancer, vascular, metabolic dysfunction-associated steatohepatitis (MASH), viral hepatitis, metabolic disorders, and others. Trend analysis was performed using Python 3.12 programming language with appropriate libraries.</p><p><strong>Results: </strong>A total of 1579 patients, 59.9% male with a mean age of 45.12 years (SD: 13.52), were analyzed. Autoimmune disorders emerged as the leading cause of LT, increasing from 32.2% in 2020 to 40.6% in 2024 (p-trend = 0.039). Viral hepatitis cases decreased significantly from 18.1% to 3.0% (p-trend = 0.033). Liver cancer became the third leading cause in 2021, replacing viral hepatitis, while MASH consistently remained the second leading cause.</p><p><strong>Conclusion: </strong>The significant shifts in LT etiologies underscore the success of public health interventions in reducing the burden of viral-related ESLD. Additionally, the findings highlight the need for ongoing research into the prevention, early diagnosis, and management of autoimmune liver diseases, MASH, and liver cancer. These findings provide critical insights for clinicians and policymakers to enhance liver disease management and allocate resources effectively.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 1","pages":"115-119"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301539/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144741953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helicobacter pylori infection in patients with colorectal adenocarcinoma and its association with tumor grade and location: a cross-sectional study. 结直肠腺癌患者幽门螺杆菌感染及其与肿瘤分级和部位的关系:一项横断面研究
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i2.3090
Elham Pishgar, Hoda Mahdavi

Aim: Given the positive results of some research, this study aimed to explore the relationship between the presence of Helicobacter pylori (HP) in gastric histopathology and the location and grade of tumors in an institutional sample of patients diagnosed with colorectal cancer (CRC).

Background: Epidemiological studies have been conducted to investigate the association between HP infection and CRC.

Methods: This cross-sectional study retrieved data from the hospital database, considering inclusion criteria and medical record availability for patients who underwent both endoscopy and colonoscopy and were diagnosed with CRC. Patients were grouped based on tumor grade and location and compared regarding the presence or absence of HP pathogen in endoscopic biopsy direct smears.

Results: Data from 241 patients were available, 220 of whom had adenocarcinoma. A statistically significant relationship between tumor differentiation grade and HP positivity was observed (P= 0.001). Each 1-level increase in grade was associated with 2.2 times higher odds of HP positivity. No significant relationships existed in the analysis of tumor location related to HP positivity.

Conclusion: In colorectal cancer patients, the presence of the HP pathogen may be linked to a higher likelihood of high-grade colorectal cancers. This finding needs to be explored in screening cohorts.

目的:鉴于一些研究的阳性结果,本研究旨在探讨胃组织病理学中幽门螺杆菌(HP)的存在与结直肠癌(CRC)患者肿瘤的位置和分级之间的关系。背景:流行病学研究调查了HP感染与结直肠癌之间的关系。方法:本横断面研究从医院数据库中检索数据,考虑了内镜和结肠镜检查并诊断为结直肠癌的患者的纳入标准和病历可用性。根据肿瘤分级和位置对患者进行分组,并比较内镜活检直接涂片中HP病原体的存在或不存在。结果:241例患者资料可查,其中220例为腺癌。肿瘤分化等级与HP阳性有统计学意义(P= 0.001)。等级每增加1级,HP阳性几率增加2.2倍。HP阳性与肿瘤位置分析无显著相关性。结论:在结直肠癌患者中,HP病原体的存在可能与高级别结直肠癌的可能性有关。这一发现需要在筛查队列中进行探索。
{"title":"<i>Helicobacter pylori</i> infection in patients with colorectal adenocarcinoma and its association with tumor grade and location: a cross-sectional study.","authors":"Elham Pishgar, Hoda Mahdavi","doi":"10.22037/ghfbb.v18i2.3090","DOIUrl":"10.22037/ghfbb.v18i2.3090","url":null,"abstract":"<p><strong>Aim: </strong>Given the positive results of some research, this study aimed to explore the relationship between the presence of <i>Helicobacter pylori</i> (HP) in gastric histopathology and the location and grade of tumors in an institutional sample of patients diagnosed with colorectal cancer (CRC).</p><p><strong>Background: </strong>Epidemiological studies have been conducted to investigate the association between HP infection and CRC.</p><p><strong>Methods: </strong>This cross-sectional study retrieved data from the hospital database, considering inclusion criteria and medical record availability for patients who underwent both endoscopy and colonoscopy and were diagnosed with CRC. Patients were grouped based on tumor grade and location and compared regarding the presence or absence of HP pathogen in endoscopic biopsy direct smears.</p><p><strong>Results: </strong>Data from 241 patients were available, 220 of whom had adenocarcinoma. A statistically significant relationship between tumor differentiation grade and HP positivity was observed (P= 0.001). Each 1-level increase in grade was associated with 2.2 times higher odds of HP positivity. No significant relationships existed in the analysis of tumor location related to HP positivity.</p><p><strong>Conclusion: </strong>In colorectal cancer patients, the presence of the HP pathogen may be linked to a higher likelihood of high-grade colorectal cancers. This finding needs to be explored in screening cohorts.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 2","pages":"246-251"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421928/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145039897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First, paradigmatic case of AMA-negative primary biliary cholangiitis with rods and rings autoantibodies: report of future implications. 首先,ama阴性原发性胆道胆管炎伴棒状和环状自身抗体的典型病例:未来意义的报告。
Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-08-26 DOI: 10.22037/ghfbb.v18i3.3135
Roberto Roberto
{"title":"First, paradigmatic case of AMA-negative primary biliary cholangiitis with rods and rings autoantibodies: report of future implications.","authors":"Roberto Roberto","doi":"10.22037/ghfbb.v18i3.3135","DOIUrl":"10.22037/ghfbb.v18i3.3135","url":null,"abstract":"","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 3","pages":"264-269"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12535782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145336780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric granular cell tumor masquerading as gastrointestinal stromal tumor: a rare concept. 胃颗粒细胞瘤伪装成胃肠道间质瘤:一个罕见的概念。
Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-08-26 DOI: 10.22037/ghfbb.v18i3.3180
Swagatika Samal, Girish Kumar Pati, Kalpana Panda, Debahuti Mohaptra, Sumit Saurav Mohanty, Debakanta Mishra, Krishna Sai Sharan
{"title":"Gastric granular cell tumor masquerading as gastrointestinal stromal tumor: a rare concept.","authors":"Swagatika Samal, Girish Kumar Pati, Kalpana Panda, Debahuti Mohaptra, Sumit Saurav Mohanty, Debakanta Mishra, Krishna Sai Sharan","doi":"10.22037/ghfbb.v18i3.3180","DOIUrl":"10.22037/ghfbb.v18i3.3180","url":null,"abstract":"","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 3","pages":"365-368"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145344920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventive and therapeutic effects of cepharanthine on acetaminophen-induced acute liver and kidney injury in male laboratory mice. 头孢酞菁对对乙酰氨基酚致雄性实验小鼠急性肝肾损伤的防治作用。
Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-08-26 DOI: 10.22037/ghfbb.v18i3.3132
Neda Askaripour, Ali Akbar Oroojan, Mohammad Amin Behmanesh, Pouya Imanpour, Marjan Aliabdi, Soraya Khajerezaei

Aim: This study aimed to evaluate the preventive and therapeutic effects of cepharanthine on APAP (N-acetyl-para-aminophenol )-induced liver and kidney injury in an experimental model.

Background: Acetaminophen (APAP) is widely used as an analgesic and antipyretic drug; however, its overdose can cause acute liver and kidney injury. Cepharanthine, a natural alkaloid with antioxidant properties, has been proposed as a potential protective agent.

Methods: In this experimental study 40 Male NMRI mice were divided into five groups: Control, Sham, APAP-treated, APAP + preventive cepharanthine, and APAP + therapeutic cepharanthine groups. Liver and kidney function markers, including ALT, AST, BUN, creatinine, total antioxidant capacity (TAC), and malondialdehyde (MDA), were measured. Histopathological analysis was performed to assess tissue damage. Statistical analysis was conducted using ANOVA with a significance threshold of p < 0.05.

Results: APAP administration significantly increased ALT, AST (p < 0.001), and MDA (p < 0.01) while reducing TAC levels (p < 0.01) in liver and kidney tissues. Cepharanthine, particularly in the therapeutic group, reduced ALT levels (p < 0.05) and improved liver histology but did not significantly alter AST or TAC in the prevention group. In contrast, cepharanthine failed to improve kidney function markers and worsened histological damage, leading to increased tubular casts and hemorrhagic areas.

Conclusion: Cepharanthine exhibited partial hepatoprotective effects against APAP-induced liver injury but did not improve kidney damage. So, this natural alkaloid does not confer a significant protective effect against acute kidney injury.

目的:本研究旨在评价天麻苷对APAP (n -乙酰-对氨基酚)致大鼠肝肾损伤的预防和治疗作用。背景:对乙酰氨基酚(APAP)是一种广泛应用的镇痛解热药物;但过量可引起急性肝肾损伤。头孢酞碱是一种具有抗氧化特性的天然生物碱,被认为是一种潜在的保护剂。方法:将40只雄性NMRI小鼠分为5组:对照组、假手术组、APAP治疗组、APAP +预防组和APAP +治疗组。测定肝肾功能指标,包括ALT、AST、BUN、肌酐、总抗氧化能力(TAC)和丙二醛(MDA)。组织病理学分析评估组织损伤。统计学分析采用方差分析,显著性阈值p < 0.05。结果:APAP显著升高肝、肾组织中ALT、AST (p < 0.001)和MDA (p < 0.01),降低TAC (p < 0.01)水平。头孢酞氨酸,尤其是治疗组,降低了ALT水平(p < 0.05),改善了肝脏组织学,但在预防组没有显著改变AST和TAC。相比之下,头孢酞碱未能改善肾功能指标,并加重组织学损伤,导致肾小管型和出血面积增加。结论:头孢酞素对apap诱导的肝损伤有部分肝保护作用,但对肾损伤无改善作用。因此,这种天然生物碱对急性肾损伤没有显著的保护作用。
{"title":"Preventive and therapeutic effects of cepharanthine on acetaminophen-induced acute liver and kidney injury in male laboratory mice.","authors":"Neda Askaripour, Ali Akbar Oroojan, Mohammad Amin Behmanesh, Pouya Imanpour, Marjan Aliabdi, Soraya Khajerezaei","doi":"10.22037/ghfbb.v18i3.3132","DOIUrl":"10.22037/ghfbb.v18i3.3132","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to evaluate the preventive and therapeutic effects of cepharanthine on APAP (N-acetyl-para-aminophenol )-induced liver and kidney injury in an experimental model.</p><p><strong>Background: </strong>Acetaminophen (APAP) is widely used as an analgesic and antipyretic drug; however, its overdose can cause acute liver and kidney injury. Cepharanthine, a natural alkaloid with antioxidant properties, has been proposed as a potential protective agent.</p><p><strong>Methods: </strong>In this experimental study 40 Male NMRI mice were divided into five groups: Control, Sham, APAP-treated, APAP + preventive cepharanthine, and APAP + therapeutic cepharanthine groups. Liver and kidney function markers, including ALT, AST, BUN, creatinine, total antioxidant capacity (TAC), and malondialdehyde (MDA), were measured. Histopathological analysis was performed to assess tissue damage. Statistical analysis was conducted using ANOVA with a significance threshold of p < 0.05.</p><p><strong>Results: </strong>APAP administration significantly increased ALT, AST (p < 0.001), and MDA (p < 0.01) while reducing TAC levels (p < 0.01) in liver and kidney tissues. Cepharanthine, particularly in the therapeutic group, reduced ALT levels (p < 0.05) and improved liver histology but did not significantly alter AST or TAC in the prevention group. In contrast, cepharanthine failed to improve kidney function markers and worsened histological damage, leading to increased tubular casts and hemorrhagic areas.</p><p><strong>Conclusion: </strong>Cepharanthine exhibited partial hepatoprotective effects against APAP-induced liver injury but did not improve kidney damage. So, this natural alkaloid does not confer a significant protective effect against acute kidney injury.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 3","pages":"321-332"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12535781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145336805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of success rates in intussusception reduction in children: colonoscopy versus ultrasound-guided saline enema. 儿童肠套叠复位成功率的比较:结肠镜检查与超声引导盐水灌肠。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i2.3116
Reyhaneh Naghizadeh, Ahmad Ali Davar, Alireza Teimouri, Manijeh Khalili, Mohadeseh Zadehmir

Aim: This study evaluated and compared the success rates of intussusception reduction in children younger under three years of age using colonoscopy versus ultrasound-guided saline enema.

Background: Intussusception involves telescoping one segment of the intestine into another.

Methods: This experimental study included 41 children under three years old who were diagnosed with intussusception via ultrasound and admitted for reduction treatment. Participants were randomly assigned to either the saline enema or colonoscopy intervention. Data analysis was conducted using Chi-square tests and independent T-tests, utilizing SPSS 23.

Results: Among the 41 children, 16 underwent reduction via colonoscopy, achieving a success rate of 81.25% (13 out of 16). In contrast, the saline enema method demonstrated a success rate of 84% (21 out of 25). The difference in success rates between the two methods was not statistically significant. Factors such as gender, age, the location of intussusception (ileocolic vs. colocolic), and the size of the intussusception did not significantly influence the success rates for either approach. Notably, intra-abdominal free fluid was significantly associated with reduced success rates for the saline enema method (P = 0.044). At the same time, no such association was found for the colonoscopy method (P = 0.142). Additionally, the presence of lymphadenopathy between the invaginated segments significantly impacted the success of the saline enema method (P = 0.036) but did not affect colonoscopy outcomes (P = 0.375).

Conclusion: The study concluded that there was no significant difference in the success rates of intussusception reductions between the colonoscopy and saline enema methods. Lymph nodes between invaginated loops and intraperitoneal fluid significantly decrease the success rate of saline enema reductions, suggesting that colonoscopy may be preferable in such cases.

目的:本研究评估并比较了三岁以下儿童使用结肠镜检查和超声引导盐水灌肠治疗肠套叠的成功率。背景:肠套叠涉及肠的一段延伸到另一段。方法:本实验研究纳入41例3岁以下经超声诊断为肠套叠并接受复位治疗的儿童。参与者被随机分配到盐水灌肠或结肠镜检查干预组。数据分析采用卡方检验和独立t检验,使用SPSS 23软件。结果:41例患儿中,结肠镜复位16例,成功率81.25%(13 / 16)。相比之下,盐水灌肠法的成功率为84%(25例中有21例)。两种方法的成功率差异无统计学意义。性别、年龄、肠套叠的位置(回肠结肠或结肠)以及肠套叠的大小等因素对两种入路的成功率都没有显著影响。值得注意的是,腹腔内游离液体与盐水灌肠法的成功率降低显著相关(P = 0.044)。同时,结肠镜检查方法没有发现这种关联(P = 0.142)。此外,内翻节段之间淋巴结病变的存在显著影响生理盐水灌肠方法的成功(P = 0.036),但不影响结肠镜检查结果(P = 0.375)。结论:结肠镜检查与生理盐水灌肠方法在肠套叠复位成功率上无显著差异。内陷环和腹腔内液之间的淋巴结显著降低盐水灌肠减少的成功率,提示在这种情况下结肠镜检查可能更好。
{"title":"Comparison of success rates in intussusception reduction in children: colonoscopy versus ultrasound-guided saline enema.","authors":"Reyhaneh Naghizadeh, Ahmad Ali Davar, Alireza Teimouri, Manijeh Khalili, Mohadeseh Zadehmir","doi":"10.22037/ghfbb.v18i2.3116","DOIUrl":"10.22037/ghfbb.v18i2.3116","url":null,"abstract":"<p><strong>Aim: </strong>This study evaluated and compared the success rates of intussusception reduction in children younger under three years of age using colonoscopy versus ultrasound-guided saline enema.</p><p><strong>Background: </strong>Intussusception involves telescoping one segment of the intestine into another.</p><p><strong>Methods: </strong>This experimental study included 41 children under three years old who were diagnosed with intussusception via ultrasound and admitted for reduction treatment. Participants were randomly assigned to either the saline enema or colonoscopy intervention. Data analysis was conducted using Chi-square tests and independent T-tests, utilizing SPSS 23.</p><p><strong>Results: </strong>Among the 41 children, 16 underwent reduction via colonoscopy, achieving a success rate of 81.25% (13 out of 16). In contrast, the saline enema method demonstrated a success rate of 84% (21 out of 25). The difference in success rates between the two methods was not statistically significant. Factors such as gender, age, the location of intussusception (ileocolic vs. colocolic), and the size of the intussusception did not significantly influence the success rates for either approach. Notably, intra-abdominal free fluid was significantly associated with reduced success rates for the saline enema method (P = 0.044). At the same time, no such association was found for the colonoscopy method (P = 0.142). Additionally, the presence of lymphadenopathy between the invaginated segments significantly impacted the success of the saline enema method (P = 0.036) but did not affect colonoscopy outcomes (P = 0.375).</p><p><strong>Conclusion: </strong>The study concluded that there was no significant difference in the success rates of intussusception reductions between the colonoscopy and saline enema methods. Lymph nodes between invaginated loops and intraperitoneal fluid significantly decrease the success rate of saline enema reductions, suggesting that colonoscopy may be preferable in such cases.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 2","pages":"196-204"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145040002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ERCP and complications of small bowel perforation. ERCP与小肠穿孔的并发症。
Q3 Medicine Pub Date : 2025-01-01 DOI: 10.22037/ghfbb.v18i1.3012
Hesameddin Eghlimi, Amir Sadeghi, Amirhassan Rabbani, Hamidreza Movahedi

Endoscopic retrograde cholangiopancreatography (ERCP) has become an essential treatment modality for managing biliary and pancreatic disorders. However, perforation remains one of the most concerning complications associated with ERCP and endoscopic sphincterotomy. While the incidence of perforation following ERCP is relatively low, the associated mortality rate can reach 7.8%. Diagnosis and management of perforations depend on the injury's mechanism, location, and extent, as clinical and radiographic findings suggest. This paper provides a detailed overview of the causes, classification, diagnosis, management, and prevention strategies for ERCP-related perforations.

内镜逆行胰胆管造影(ERCP)已成为治疗胆道和胰腺疾病的基本治疗方式。然而,穿孔仍然是ERCP和内镜下括约肌切开术最令人担忧的并发症之一。ERCP术后穿孔的发生率相对较低,但相关死亡率可达7.8%。穿孔的诊断和处理取决于损伤的机制、位置和程度,正如临床和放射学所显示的那样。本文详细介绍了ercp相关穿孔的原因、分类、诊断、管理和预防策略。
{"title":"ERCP and complications of small bowel perforation.","authors":"Hesameddin Eghlimi, Amir Sadeghi, Amirhassan Rabbani, Hamidreza Movahedi","doi":"10.22037/ghfbb.v18i1.3012","DOIUrl":"10.22037/ghfbb.v18i1.3012","url":null,"abstract":"<p><p>Endoscopic retrograde cholangiopancreatography (ERCP) has become an essential treatment modality for managing biliary and pancreatic disorders. However, perforation remains one of the most concerning complications associated with ERCP and endoscopic sphincterotomy. While the incidence of perforation following ERCP is relatively low, the associated mortality rate can reach 7.8%. Diagnosis and management of perforations depend on the injury's mechanism, location, and extent, as clinical and radiographic findings suggest. This paper provides a detailed overview of the causes, classification, diagnosis, management, and prevention strategies for ERCP-related perforations.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301534/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144741952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastroenterology and Hepatology From Bed to Bench
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1